However, to the best of our knowledge, this is the first study examining the excretion of biomolecules influencing the PI3K/AKT/mTOR signaling pathway in albuminuric and non-albuminuric CKD in T2D. The gene discussed is AKT1; the disease is chronic kidney disease.